110 Kittrell Street, Hohenwald, TN 38462 Phone: (931) 295-3406 Mon-Fri 9:00am - 5:30pm | Sat 9:00am - 12:00pm | Sun Closed
Duren Apothecary Logo

Get Healthy!

  • Posted April 9, 2025

Experimental Drug Shows Promise in Slowing Disability from Multiple Sclerosis

Results of a phase 3 clinical trial show an experimental drug called tolebrutinib can delay disability in patients with non-relapsing secondary progressive multiple sclerosis.

Health News is provided as a service to Duren Apothecary site users by HealthDay. Duren Apothecary nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2025 HealthDay All Rights Reserved.